Terms ending in 2034
Every in-force patent on Merial, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,585,871 | Method for Treating and Curing Leishmaniosis Using Fexinidazole In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 9,556,419 | Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 10,327,446 | Naphthyl- or isoquinolinyl-substituted isothiazoline compounds In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 9,504,740 | Haemophilus Parasuis Vaccine Serovar Type Four In force · Medium confidence | Vaxxinova US, Inc. | In force | Medium confidence | |
| US 9,447,084 | Antiparisitic and Pesticidal Isoxazoline Compounds In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 9,757,445 | Attenuated Pasteurella Multocida Vaccines & Methods of Making & Use Thereof In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 10,603,371 | Attenuated Pasteurella Multocida Vaccines & Methods of Making & Use Thereof In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Merial, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.